Finance

Lists
Why is MDMA down 6,98%?
Dive Deeper
MDMA:CNSX
Pharmala Biotech Holdings Inc
CA$0,20
-6,98%
(-0,015) 1D
13 ຕ.ລ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for MDMA...
Open
CA$0,21
High
CA$0,21
Low
CA$0,18
Mkt. cap
21,23 ລ້ານ
Avg. vol.
167,64 ພັນ
Volume
156,42 ພັນ
52-wk high
CA$0,33
52-wk low
CA$0,08
EPS
CA$-0,02
No. of employees
3
Open
CA$0,21
High
CA$0,21
Low
CA$0,18
Mkt. cap
21,23 ລ້ານ
Avg. vol.
167,64 ພັນ
Volume
156,42 ພັນ
52-wk high
CA$0,33
52-wk low
CA$0,08
EPS
CA$-0,02
No. of employees
3
News stories
From web sources and news partners
StockStory
StockStory
·
30 ນາທີກ່ອນ
1 S&P 500 Stock with Competitive Advantages and 2 We Brush Off
MarketBeat
MarketBeat
·
54 ນາທີກ່ອນ
X-Energy (NASDAQ:XE) Reaches New 12-Month Low - Time to Sell?
Investor's Business Daily
Investor's Business Daily
·
32 ນາທີກ່ອນ
Dow Futures Rise; ASML Earnings Beat, CPI Inflation Due
Seeking Alpha
Seeking Alpha
·
2 ຊົ່ວໂມງກ່ອນ
Dow Jones Industrial Average Monitor Update - A Look At 30 U.S. Large-Caps
About Pharmala Biotech Holdings Inc
CEO-
Employees3
Founded2021
Headquartersໂຕຣອນໂຕ, ອອນທາຣິໂອ, ແຄນາດາ
SectorBiotechnology
Websitepharmala.ca
Last report
29 ກ.ລ. 2026
Fiscal period
Q3 2026
- / -
Revenue / Est. (CAD)
513,23 ພັນ / -
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
ສ.ຫ. 2025
ພ.ຈ. 2025
ກ.ພ. 2026
ພ.ພ. 2026
Revenue
267,38 ພັນ
206,44 ພັນ
280,58 ພັນ
513,23 ພັນ
Cost of goods sold
34,04 ພັນ
34,84 ພັນ
22,41 ພັນ
174,69 ພັນ
Cost of revenue
34,04 ພັນ
34,84 ພັນ
22,41 ພັນ
174,69 ພັນ
Research and development expenses
44,91 ພັນ
41,10 ພັນ
40,53 ພັນ
44,91 ພັນ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
404,68 ພັນ
320,96 ພັນ
367,29 ພັນ
472,32 ພັນ
Operating expense
553,47 ພັນ
498,41 ພັນ
559,82 ພັນ
810,59 ພັນ
Total operating expenses
587,50 ພັນ
533,25 ພັນ
582,22 ພັນ
985,28 ພັນ
Operating income
-320,13 ພັນ
-326,81 ພັນ
-301,64 ພັນ
-472,05 ພັນ
Other non operating income
-41,00 ພັນ
-16,84 ພັນ
-46,18 ພັນ
-40,97 ພັນ
EBT including unusual items
-361,13 ພັນ
-409,70 ພັນ
-337,70 ພັນ
-499,76 ພັນ
EBT excluding unusual items
-361,13 ພັນ
-343,65 ພັນ
-347,82 ພັນ
-513,01 ພັນ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-361,13 ພັນ
-409,70 ພັນ
-337,70 ພັນ
-499,76 ພັນ
Net profit margin
-135,07%
-198,46%
-120,35%
-97,37%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
29,19 ພັນ
29,76 ພັນ
29,74 ພັນ
30,02 ພັນ
EBITDA
-306,98 ພັນ
-313,10 ພັນ
-287,95 ພັນ
-458,08 ພັນ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
ແອັບຂອງ Google